Role of MicroRNAs in Inflammation-associated Liver Cancer

Overview

Journal Cancer Biol Med

Specialty Oncology

Date 2017 Feb 4

PMID 28154773

Citations 12

Authors

Lin Huan

Lin-Hui Liang

Xiang-Huo He

Affiliations

Soon will be listed here.

Abstract

Liver cancer, primarily hepatocellular carcinoma (HCC), is a major cause of cancer-related death worldwide. HCC is a suitable model of inflammation-induced cancer because more than 90% of HCC cases are caused by liver damage and chronic inflammation. Several inflammatory response pathways, such as NF-κB and JAK/STAT3 signaling pathways, play roles in the crosstalk between inflammation and HCC. MicroRNAs (miRNAs) are evolutionarily conserved, short endogenous, non-coding single-stranded RNAs that are involved in various biological and pathological processes by regulating gene expression and protein translation. Evidence showed that miRNAs play a pivotal role in hepatitis virus infection and serve as promoters or inhibitors of inflammatory response. Aberrant miRNA was observed during liver inflammation and HCC. Many dysregulated miRNAs modulate the initiation and progression of inflammation-induced HCC. This review summarizes the role and functions of miRNAs in inflammation-associated HCC, as well as the designed therapeutics targeting miRNAs to treat liver inflammation and HCC.

Citing Articles

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression.

Ruan L, Fang N, Zhao X, Chen W, Wu Z, Wu X Discov Oncol. 2025; 16(1):116.

PMID: 39903352 PMC: 11794919. DOI: 10.1007/s12672-025-01851-6.

Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model.

Xu X, Liu Y, Liu Y, Yu Y, Yang M, Lu L J Nanobiotechnology. 2024; 22(1):381.

PMID: 38951911 PMC: 11218144. DOI: 10.1186/s12951-024-02547-9.

Cancer of the Liver and its Relationship with Diabetes mellitus.

Onikanni S, Lawal B, Bakare O, Ajiboye B, Ojo O, Farasani A Technol Cancer Res Treat. 2022; 21:15330338221119743.

PMID: 36533882 PMC: 9772979. DOI: 10.1177/15330338221119743.

LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression.

Liu T, Liao S, Mo J, Bai X, Li Y, Zhang Y J Gastroenterol. 2022; 57(10):784-797.

PMID: 35802258 DOI: 10.1007/s00535-022-01901-8.

MicroRNA as a Potential Therapeutic Molecule in Cancer.

Szczepanek J, Skorupa M, Tretyn A Cells. 2022; 11(6).

PMID: 35326459 PMC: 8947269. DOI: 10.3390/cells11061008.

References

Yu G, Chen X, Chen S, Ye W, Hou K, Liang M . MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. J Transl Med. 2016; 14(1):122. PMC: 4858919. DOI: 10.1186/s12967-016-0888-7. View

Marquez R, Bandyopadhyay S, Wendlandt E, Keck K, Hoffer B, Icardi M . Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010; 90(12):1727-36. DOI: 10.1038/labinvest.2010.126. View

Chen M, Liu Y, Varley P, Chang Y, He X, Huang H . High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity. Cancer Res. 2015; 75(8):1645-56. PMC: 4401643. DOI: 10.1158/0008-5472.CAN-14-2147. View

You X, Liu F, Zhang T, Li Y, Ye L, Zhang X . Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis. 2013; 34(7):1644-52. DOI: 10.1093/carcin/bgt089. View

Tan G, Wu L, Tan J, Zhang B, Tai W, Xiong S . MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway. Sci Rep. 2016; 6:22328. PMC: 4772113. DOI: 10.1038/srep22328. View

Callegari E, Elamin B, DAbundo L, Falzoni S, Donvito G, Moshiri F . Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PLoS One. 2013; 8(9):e73964. PMC: 3771938. DOI: 10.1371/journal.pone.0073964. View

Zhao J, Wang W, Huang Y, Wu J, Chen M, Cui P . HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes. DNA Cell Biol. 2014; 33(10):715-22. DOI: 10.1089/dna.2014.2376. View

Escarcega R, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A . The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol). 2007; 19(2):154-61. DOI: 10.1016/j.clon.2006.11.013. View

Li J, Dai X, Zhang W, Sun S, Zeng Y, Zhao G . Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H. mBio. 2015; 6(2). PMC: 4453536. DOI: 10.1128/mBio.02459-14. View

10.

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z . Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013; 25(5):1037-43. DOI: 10.1016/j.cellsig.2013.01.019. View

11.

Yen C, Su Z, Lee Y, Liu I, Yen C . miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2016; 22(22):5183-92. PMC: 4893465. DOI: 10.3748/wjg.v22.i22.5183. View

12.

Callegari E, Elamin B, Giannone F, Milazzo M, Altavilla G, Fornari F . Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology. 2012; 56(3):1025-33. DOI: 10.1002/hep.25747. View

13.

Zhang X, Zeng J, Zhou M, Li B, Zhang Y, Huang T . The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer. 2012; 11:56. PMC: 3533721. DOI: 10.1186/1476-4598-11-56. View

14.

Huan L, Bao C, Chen D, Li Y, Lian J, Ding J . MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells. Cancer Sci. 2015; 107(3):258-66. PMC: 4814244. DOI: 10.1111/cas.12869. View

15.

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

16.

Li Y, Zhang Z, Liu X, Huang T, He W, Shen Y . miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3. Mol Cell Biochem. 2013; 388(1-2):219-31. DOI: 10.1007/s11010-013-1913-2. View

17.

Li W, Huang H, Su J, Ji X, Zhang X, Zhang Z . miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3. Mol Neurobiol. 2016; 54(4):2555-2561. DOI: 10.1007/s12035-016-9852-z. View

18.

Wang B, Hsu S, Frankel W, Ghoshal K, Jacob S . Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology. 2012; 56(1):186-97. PMC: 3355233. DOI: 10.1002/hep.25632. View

19.

Wan D, Shen S, Fu S, Preston B, Brandon C, He S . miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC. Anticancer Agents Med Chem. 2015; 16(4):414-23. DOI: 10.2174/1871520615666150716105955. View

20.

Dixon-McIver A, East P, Mein C, Cazier J, Molloy G, Chaplin T . Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One. 2008; 3(5):e2141. PMC: 2373886. DOI: 10.1371/journal.pone.0002141. View